$92.20
-1.34-1.43%
At close: Jun 12, 5:00 PM EST
$90.51
-1.69-1.83%
After Hours: Jun 12, 4:23 PM EST
Inhibrx Biosciences Inc Earnings Estimates
INBXNASDAQ
Inhibrx Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:INBX
Inhibrx Biosciences (INBX) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-1.57 and quarterly revenue of N/A.
In the most recent quarter (Q1), Inhibrx Biosciences reported EPS of $-2.15, missing estimates of $-1.43 by 0.50%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Inhibrx Biosciences has averaged an EPS surprise of 0.25% and a revenue surprise of 0.00%.
Earnings Date
Aug 12
EPS Estimate
$-1.570
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$1.30M
Inhibrx Biosciences Earnings History
Analyze the earnings history of Inhibrx Biosciences using advanced sorting and filters.
Loading calendar...
Inhibrx Biosciences (INBX) Earnings Per Share
The chart below shows Inhibrx Biosciences's reported EPS compared to analyst estimates over recent quarters.
Inhibrx Biosciences (INBX) Revenue
The chart below shows Inhibrx Biosciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?
Inhibrx Biosciences (INBX) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Inhibrx Biosciences (NASDAQ:INBX)?
The Actual EPS was $-2.15, which missed the estimate of $-1.43.
What were Inhibrx Biosciences’s (NASDAQ:INBX) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
